These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27802340)

  • 1. Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.
    Lee D; Park SM
    PLoS One; 2016; 11(11):e0165879. PubMed ID: 27802340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique.
    Klingler C; Thoumi AI; Mrithinjayam VS
    Vaccine; 2012 Dec; 31(1):252-9. PubMed ID: 22902676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the cost-effectiveness of universal hepatitis B virus vaccination in Iran: a Markov model analysis.
    Mokhtari AM; Barouni M; Moghadami M; Hassanzadeh J; Dewey RS; Mirahmadizadeh A
    Hum Vaccin Immunother; 2021 Jun; 17(6):1825-1833. PubMed ID: 33734949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.
    Devine A; Harvey R; Min AM; Gilder MET; Paw MK; Kang J; Watts I; Hanboonkunupakarn B; Nosten F; McGready R
    BMC Infect Dis; 2017 Aug; 17(1):552. PubMed ID: 28793866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Hepatitis B Birth-Dose Vaccination in São Tomé and Príncipe: A Program Assessment and Cost-Effectiveness Study.
    Hagan JE; Carvalho E; Souza V; Queresma Dos Anjos M; Abimbola TO; Pallas SW; Tevi Benissan MC; Shendale S; Hennessey K; Patel MK
    Am J Trop Med Hyg; 2019 Oct; 101(4):891-898. PubMed ID: 31392947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.
    Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
    Hepatology; 2016 May; 63(5):1471-80. PubMed ID: 26509655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
    Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study.
    Scott N; Palmer A; Morgan C; Lesi O; Spearman CW; Sonderup M; Hellard M
    Lancet Glob Health; 2018 Jun; 6(6):e659-e667. PubMed ID: 29773122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
    Jia Y; Li L; Cui F; Zhang D; Zhang G; Wang F; Gong X; Zheng H; Wu Z; Miao N; Sun X; Zhang L; Lv J; Yang F
    Hum Vaccin Immunother; 2014; 10(10):2983-91. PubMed ID: 25483678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
    Krahn M; Detsky AS
    Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea.
    Lee D; Shin HY; Park SM
    Cost Eff Resour Alloc; 2018; 16():6. PubMed ID: 29467596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Benefit Analysis of Vaccination Strategies to Prevent Mother-to-Child Transmission of the Hepatitis B Virus Using a Markov Model Decision Tree.
    Yang N; Lei L; Meng Y; Zhou N; Shi L; Hu M
    Front Public Health; 2022; 10():662442. PubMed ID: 35801242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.
    Tamandjou Tchuem CR; Andersson MI; Wiysonge CS; Mufenda J; Preiser W; Cleary S
    Vaccine; 2021 May; 39(23):3141-3151. PubMed ID: 33962836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).
    Gosset A; Diallo MY; Betsem E; Schaeffer L; Meda N; Vray M; Sombie R; Shimakawa Y; Boyer S
    Vaccine; 2021 Jul; 39(33):4659-4670. PubMed ID: 34238606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.
    Hutton DW; Tan D; So SK; Brandeau ML
    Ann Intern Med; 2007 Oct; 147(7):460-9. PubMed ID: 17909207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses.
    Jakiche R; Borrego ME; Raisch DW; Gupchup GV; Pai MA; Jakiche A
    Am J Med Sci; 2007 Jan; 333(1):26-34. PubMed ID: 17220691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis.
    Bierhoff M; Angkurawaranon C; Rijken MJ; Sriprawa K; Kobphan P; Nosten FN; van Vugt M; McGready R; Devine A
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):157. PubMed ID: 33618698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of antiviral treatment for pregnant women with high viral load to prevent hepatitis B virus vertical transmission.
    Ma T; Lee LY; Aw MM; Lee GH
    Singapore Med J; 2020 Jan; 61(1):24-27. PubMed ID: 31388686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.